TRT Nation prescribes tirzepatide, not semaglutide, because the evidence supports it as the superior choice for appropriate candidates
Phase 2 study of sodium phenylbutyrate in ALS
Kyle Wood, M.D., MBA, associate professor in the UAB Department of Urology, explains what current evidence shows and why hydration remains essential for anyone using these medications
Retatrutide is a "triple-agonist," targeting GLP-1, GIP, and glucagon receptors simultaneously
Patients shouldnt attempt to take a double dose to make up for a missed dose
The research underlines the potential of dietary interventions and probiotics in supporting GLP-1 production